540 A novel antibody that induces PD-L1 degradation results in enhanced tumor responses in a humanized PD-L1 breast carcinoma mouse model compared to Atezolizumab
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMJ Publishing Group
2023-11-01
|
| Serija: | Journal for ImmunoTherapy of Cancer |